Literature DB >> 14577614

Effects of 2-amino-4,6-dinitrotoluene on p53 tumor suppressor gene expression.

Hirendra Banerjee1, Zack Hawkins, Sisir Dutta, Duane Smoot.   

Abstract

2-Amino-4,6-dinitrotoluene (2-Am-DNT) and its isomers are the most common metabolites of 2,4,6-trinitrotoluene (TNT). It is desirable to know the toxicity of this metabolite particularly because of its role in carcinogenicity and because it could contaminate drinking water. We used MCF-7 human breast cancer cells which have p53 tumor suppressor gene in wild type form in both the loci. Immunoblotting with p53 antibody showed enhanced p53 level in treated cells compared to untreated control cells. Similarly, p53 DNA-protein binding assays (gel-shift) showed accumulation of p53 protein in treated cells. This is the first report which shows p53 accumulation in 2-Am-DNT treated cells providing evidence of potential carcinogenic effects of 2-Am-DNT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14577614     DOI: 10.1023/a:1025542429071

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  10 in total

1.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

2.  The p53 proto-oncogene can act as a suppressor of transformation.

Authors:  C A Finlay; P W Hinds; A J Levine
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

3.  Increased p53 site-specific DNA binding in cells producing mutant p53.

Authors:  C Dees; C C Travis
Journal:  Cancer Lett       Date:  1995-09-25       Impact factor: 8.679

4.  Cytotoxicity and mutagenicity of 2,4,6-trinitrotoluene and its metabolites.

Authors:  M E Honeycutt; A S Jarvis; V A McFarland
Journal:  Ecotoxicol Environ Saf       Date:  1996-12       Impact factor: 6.291

5.  Epitope analysis of the murine p53 tumour suppressor protein.

Authors:  D P Lane; C W Stephen; C A Midgley; A Sparks; T R Hupp; D A Daniels; R Greaves; A Reid; B Vojtesek; S M Picksley
Journal:  Oncogene       Date:  1996-06-06       Impact factor: 9.867

6.  Abnormal expression of wild type p53 protein in normal cells of a cancer family patient.

Authors:  D M Barnes; A M Hanby; C E Gillett; S Mohammed; S Hodgson; L G Bobrow; I M Leigh; T Purkis; C MacGeoch; N K Spurr
Journal:  Lancet       Date:  1992-08-01       Impact factor: 79.321

7.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.

Authors:  J V Gannon; R Greaves; R Iggo; D P Lane
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

9.  Carcinogenic potential of benzene and toluene when evaluated using cyclin-dependent kinase activation and p53-DNA binding.

Authors:  C Dees; M Askari; D Henley
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

10.  Cytotoxicity of TNT and its metabolites.

Authors:  H N Banerjee; M Verma; L H Hou; M Ashraf; S K Dutta
Journal:  Yale J Biol Med       Date:  1999 Jan-Feb
  10 in total
  1 in total

1.  Cancer of the urinary bladder in highly exposed workers in the production of dinitrotoluenes: a case report.

Authors:  Volker Harth; Hermann M Bolt; Thomas Brüning
Journal:  Int Arch Occup Environ Health       Date:  2005-10-12       Impact factor: 3.015

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.